Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for ESA hyporesponsiveness in hemodialysis
NCT03800433Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Oct 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of pentoxifylline in Anemia In Chronic Kidney Disease (2 arms), sponsored by Ain Shams University. Primary endpoints: Hemoglobin concentration at 6 months, Hematocrit concentration at 6 months and 1 more. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
Anemia In Chronic Kidney Disease
Beyond the preview
Go deeper on NCT03800433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800433.